Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Michel Azorin

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|September 15, 2020
Antipsychotic polypharmacy in schizophrenia: evolving evidence and rationaleJean-Michel Azorin, Nicolas Simon
Neuropsychiatric Disease and Treatment|April 15, 2014
Effectiveness of methylphenidate as augmentation therapy after failure of adjunctive neuromodulation for patients with treatment-refractory bipolar depression: a case reportMarc Adida, Jean-Michel Azorin
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 15, 2014
Clinical decision making in the treatment of mixed statesHeinz Grunze, Jean Michel Azorin
American Journal of Medical Genetics|November 29, 2002
Schizophrenia: two-faced meaning of vulnerabilityJean-Michel Azorin, Jean Naudin
Drugs|August 31, 2019
Dopamine Receptor Partial Agonists for the Treatment of Bipolar DisorderJean-Michel Azorin, Nicolas Simon
Expert Opinion on Pharmacotherapy|February 25, 2009
An update on the treatment of bipolar depressionJean-Michel Azorin, Arthur Kaladjian
Expert Opinion on Pharmacotherapy|July 19, 2012
Clozapine for the treatment of schizophreniaEric Fakra, Jean-Michel Azorin
CNS Drugs|November 21, 2007
Valproate use in children and adolescents with bipolar disorderJean Michel Azorin, Robert L Findling
Medicina (Kaunas, Lithuania)|August 27, 2021
The Impact of Bipolar Disorder on Couple Functioning: Implications for Care and Treatment. A Systematic ReviewJean-Michel Azorin, Antoine Lefrere, Raoul Belzeaux
Expert Opinion on Drug Metabolism & Toxicology|August 18, 2022
Comorbidities and the right dose: antipsychoticsNicolas Simon, Romain Torrents, Jean-Michel Azorin
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Expert Opinion on Drug Metabolism & Toxicology|September 15, 2020
Antipsychotic polypharmacy in schizophrenia: evolving evidence and rationaleJean-Michel Azorin, Nicolas Simon
Neuropsychiatric Disease and Treatment|April 15, 2014
Effectiveness of methylphenidate as augmentation therapy after failure of adjunctive neuromodulation for patients with treatment-refractory bipolar depression: a case reportMarc Adida, Jean-Michel Azorin
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 15, 2014
Clinical decision making in the treatment of mixed statesHeinz Grunze, Jean Michel Azorin
American Journal of Medical Genetics|November 29, 2002
Schizophrenia: two-faced meaning of vulnerabilityJean-Michel Azorin, Jean Naudin
Drugs|August 31, 2019
Dopamine Receptor Partial Agonists for the Treatment of Bipolar DisorderJean-Michel Azorin, Nicolas Simon
Expert Opinion on Pharmacotherapy|February 25, 2009
An update on the treatment of bipolar depressionJean-Michel Azorin, Arthur Kaladjian
Expert Opinion on Pharmacotherapy|July 19, 2012
Clozapine for the treatment of schizophreniaEric Fakra, Jean-Michel Azorin
CNS Drugs|November 21, 2007
Valproate use in children and adolescents with bipolar disorderJean Michel Azorin, Robert L Findling
Medicina (Kaunas, Lithuania)|August 27, 2021
The Impact of Bipolar Disorder on Couple Functioning: Implications for Care and Treatment. A Systematic ReviewJean-Michel Azorin, Antoine Lefrere, Raoul Belzeaux
Expert Opinion on Drug Metabolism & Toxicology|August 18, 2022
Comorbidities and the right dose: antipsychoticsNicolas Simon, Romain Torrents, Jean-Michel Azorin
Pageof 15